Silo Pharma (SILO) Long-Term Deferred Tax (2017 - 2026)
Silo Pharma (SILO) posted Long-Term Deferred Tax of $2.5 million for Q4 2023, up 63.74% sequentially from $1.6 million in Q4 2022, and up 63.74% YoY from $1.6 million in Q4 2022.
Silo Pharma (SILO) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends
Silo Pharma has reported Long-Term Deferred Tax for 7 years, with the latest figure at $2.5 million in Q4 2023.
- Quarterly Long-Term Deferred Tax rose 63.74% year-over-year to $2.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.5 million (up 63.74% YoY) and the FY2023 annual result came in at $2.5 million, up 63.74% from the prior year.
- Long-Term Deferred Tax rose to $2.5 million in Q4 2023 per SILO's latest filing, from $1.6 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $2.5 million in Q4 2023 and troughed at $490819.0 in Q4 2019.
- A 5-year average of $1.2 million and a median of $868338.0 in 2020 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax decreased 29.8% in 2021, then soared 154.36% in 2022.
- Over 5 years, Long-Term Deferred Tax stood at $490819.0 in 2019, then jumped by 76.92% to $868338.0 in 2020, then fell by 29.8% to $609530.0 in 2021, then soared by 154.36% to $1.6 million in 2022, then jumped by 63.74% to $2.5 million in 2023.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $2.5 million, $1.6 million, and $609530.0 for Q4 2023, Q4 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26,997.00 |
| Dec 31, 2023 | 2.54 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 609,530.00 |
| Dec 31, 2020 | 868,338.00 |
| Dec 31, 2019 | 490,819.00 |
| Dec 31, 2018 | 498,493.00 |
| Dec 31, 2017 | 89,244.00 |